Anti-müllerian Hormone As a Predictor for Live Birth Among Women Undergoing IVF/ICSI in Different Age Groups: an Update of Systematic Review and Meta-analysis

Overview

Journal Arch Gynecol Obstet

Specialty Gynecology & Obstetrics

Date 2022 Jul 30

PMID 35907969

Authors

Ni-Jie Li

Qing-Yun Yao

Xiao-Qiong Yuan

Yong Huang

Yu-Feng Li

Affiliations

Soon will be listed here.

Abstract

Purpose: To update the evidence of anti-müllerian hormone (AMH) as predictive factors for live birth outcome in women undergoing assisted conception and discover the modulating effect of age.

Methods: PubMed, Embase, Medline, and Web of Science were searched for studies published until June 2021. We included studies that measured serum AMH levels and reported the subsequent live birth outcomes. Random effects models and hierarchical summary receiver operating characteristics (HSROC) models were used. The QUADAS-2 checklist was employed to assess the quality of the included studies.

Results: We included 27 studies (27,029 women) investigating the relationship between AMH and live birth outcome after assisted conception. The diagnostic odds ratios (DOR) from random effects models were ruled out due to high heterogeneity. Our findings suggested that AMH was associated with live birth. The DOR was 2.21 (95% CI 1.89-2.59), and 2.49 (95% CI 1.26-4.91) for studies on women with unspecified ovarian reserve and women with low ovarian reserve, respectively. The DOR of those with advanced ages was 2.50 (95% CI 1.87-2.60). For younger women, the DOR was 1.41 (95% CI 0.99-2.02). HSROCs showed that AMH had no predictive ability towards live birth in women with diminished ovarian reserve or younger age. Exclusion of Chinese cohorts lowered the heterogeneity.

Conclusions: This study revealed that AMH had better prediction for live birth in advanced-age women. AMH may have implicative predictive value for assisted conception counseling of couples of advanced ages.

Citing Articles

Derivation and validation of the first web-based nomogram to predict the spontaneous pregnancy after reproductive surgery using machine learning models.

Liu Z, Wang M, He S, Wang X, Liu X, Xie X Front Endocrinol (Lausanne). 2024; 15:1378157.

PMID: 39015183 PMC: 11250273. DOI: 10.3389/fendo.2024.1378157.

Anti-Müllerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome?.

Vale-Fernandes E, Moreira M, Rodrigues B, Pereira S, Leal C, Barreiro M Front Cell Dev Biol. 2024; 12:1408879.

PMID: 39011395 PMC: 11246868. DOI: 10.3389/fcell.2024.1408879.

The impact of ovarian endometrioma and endometriotic cystectomy on anti-Müllerian hormone, and antral follicle count: a contemporary critical appraisal of systematic reviews.

Younis J, Taylor H Front Endocrinol (Lausanne). 2024; 15:1397279.

PMID: 38800489 PMC: 11116636. DOI: 10.3389/fendo.2024.1397279.

Endometrial Elasticity is an Ultrasound Marker for Predicting Clinical Pregnancy Outcomes after Embryo Transfer.

Zhang L, Huang S, Wang L, Wang Y, Lu S, Li R Reprod Sci. 2024; 32(1):64-73.

PMID: 38769248 PMC: 11729198. DOI: 10.1007/s43032-024-01565-0.

Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome.

Vale-Fernandes E, Barreiro M, Leal C, Macedo R, Tome A, Monteiro M Biomedicines. 2023; 11(12).

PMID: 38137371 PMC: 10740605. DOI: 10.3390/biomedicines11123150.

References

Seifer D, MacLaughlin D . Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertil Steril. 2007; 88(3):539-46. DOI: 10.1016/j.fertnstert.2007.02.014. View

Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M . Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?. BJOG. 2004; 111(11):1248-53. DOI: 10.1111/j.1471-0528.2004.00452.x. View

La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio A . Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2009; 16(2):113-30. DOI: 10.1093/humupd/dmp036. View

Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri D, Serhal P . Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?. BJOG. 2005; 112(10):1384-90. DOI: 10.1111/j.1471-0528.2005.00670.x. View

Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate R, Skakkebaek N . Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab. 1999; 84(10):3836-44. DOI: 10.1210/jcem.84.10.6047. View

Pellatt L, Rice S, D Mason H . Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?. Reproduction. 2010; 139(5):825-33. DOI: 10.1530/REP-09-0415. View

Iliodromiti S, Kelsey T, Wu O, Anderson R, Nelson S . The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014; 20(4):560-70. DOI: 10.1093/humupd/dmu003. View

Tal R, Tal O, Seifer B, Seifer D . Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2014; 103(1):119-30.e3. DOI: 10.1016/j.fertnstert.2014.09.041. View

Wang J, Douglas N, Nakhuda G, Choi J, Park S, Thornton M . The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age. Reprod Biomed Online. 2010; 21(6):757-61. DOI: 10.1016/j.rbmo.2010.06.041. View

10.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. PMC: 2714672. DOI: 10.1136/bmj.b2700. View

11.

Whiting P, Rutjes A, Westwood M, Mallett S, Deeks J, Reitsma J . QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155(8):529-36. DOI: 10.7326/0003-4819-155-8-201110180-00009. View

12.

Lin W, Yao L, Zhang D, Zhang W, Yang X, Yu R . The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET). J Assist Reprod Genet. 2013; 30(5):649-55. PMC: 3663964. DOI: 10.1007/s10815-013-9973-5. View

13.

Mutlu M, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O . Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet. 2013; 30(5):657-65. PMC: 3663963. DOI: 10.1007/s10815-013-9975-3. View

14.

Lukaszuk K, Liss J, Kunicki M, Jakiel G, Wasniewski T, Woclawek-Potocka I . Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology. Reprod Biol. 2014; 14(3):176-81. DOI: 10.1016/j.repbio.2014.03.004. View

15.

Li H, Lee V, Lau E, Yeung W, Ho P, Ng E . Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study. PLoS One. 2014; 9(10):e108493. PMC: 4196774. DOI: 10.1371/journal.pone.0108493. View

16.

Stochino-Loi E, Darwish B, Mircea O, Touleimat S, Millochau J, Abo C . Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis?. Fertil Steril. 2017; 107(3):707-713.e3. DOI: 10.1016/j.fertnstert.2016.12.013. View

17.

McCormack C, Leemaqz S, Furness D, Dekker G, Roberts C . Anti-Müllerian hormone levels in recurrent embryonic miscarriage patients are frequently abnormal, and may affect pregnancy outcomes. J Obstet Gynaecol. 2019; 39(5):623-627. DOI: 10.1080/01443615.2018.1552669. View

18.

Tal R, Seifer D, Wantman E, Baker V, Tal O . Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013. Fertil Steril. 2018; 109(2):258-265. DOI: 10.1016/j.fertnstert.2017.10.021. View

19.

Ligon S, Lustik M, Levy G, Pier B . Low antimüllerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle-stimulating hormone and AMH are discordant. Fertil Steril. 2019; 112(1):73-81.e1. DOI: 10.1016/j.fertnstert.2019.03.022. View

20.

Hamdine O, Eijkemans M, Lentjes E, Torrance H, Macklon N, Fauser B . Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization. Fertil Steril. 2015; 104(4):891-898.e2. DOI: 10.1016/j.fertnstert.2015.06.030. View